Anebulo Pharmaceuticals, Inc.ANEBNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-0.63%
↑ 100% above average
Average (21q)
-240.87%
Historical baseline
Range
High:94.66%
Low:-5137.55%
Volatility
-2172.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -0.63% |
| Q2 2025 | -27.96% |
| Q1 2025 | 31.95% |
| Q4 2024 | -11.90% |
| Q3 2024 | -63.04% |
| Q2 2024 | 18.36% |
| Q1 2024 | 39.15% |
| Q4 2023 | -9.53% |
| Q3 2023 | 0.58% |
| Q2 2023 | 10.81% |
| Q1 2023 | 26.89% |
| Q4 2022 | -46.52% |
| Q3 2022 | -12.45% |
| Q2 2022 | -23.78% |
| Q1 2022 | -74.88% |
| Q4 2021 | 30.93% |
| Q3 2021 | 94.66% |
| Q2 2021 | -5137.55% |
| Q1 2021 | -69.15% |
| Q4 2020 | -28.17% |
| Q3 2020 | -46.81% |
| Q2 2020 | 0.00% |